AU7154998A - Prevention and treatment of allergic disease by targeted development of protective t-helper lymphocyte immunity - Google Patents

Prevention and treatment of allergic disease by targeted development of protective t-helper lymphocyte immunity

Info

Publication number
AU7154998A
AU7154998A AU71549/98A AU7154998A AU7154998A AU 7154998 A AU7154998 A AU 7154998A AU 71549/98 A AU71549/98 A AU 71549/98A AU 7154998 A AU7154998 A AU 7154998A AU 7154998 A AU7154998 A AU 7154998A
Authority
AU
Australia
Prior art keywords
prevention
protective
treatment
allergic disease
helper lymphocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71549/98A
Inventor
David E. Bice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lovelace Respiratory Research Institute
Original Assignee
Lovelace Respiratory Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lovelace Respiratory Research Institute filed Critical Lovelace Respiratory Research Institute
Publication of AU7154998A publication Critical patent/AU7154998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU71549/98A 1997-04-24 1998-04-23 Prevention and treatment of allergic disease by targeted development of protective t-helper lymphocyte immunity Abandoned AU7154998A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US4460497P 1997-04-24 1997-04-24
US60044604 1997-04-24
US93528297A 1997-09-22 1997-09-22
US08935282 1997-09-22
US6449498A 1998-04-22 1998-04-22
US09064494 1998-04-22
PCT/US1998/008248 WO1998047520A1 (en) 1997-04-24 1998-04-23 Prevention and treatment of allergic disease by targeted development of protective t-helper lymphocyte immunity

Publications (1)

Publication Number Publication Date
AU7154998A true AU7154998A (en) 1998-11-13

Family

ID=27366520

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71549/98A Abandoned AU7154998A (en) 1997-04-24 1998-04-23 Prevention and treatment of allergic disease by targeted development of protective t-helper lymphocyte immunity

Country Status (2)

Country Link
AU (1) AU7154998A (en)
WO (1) WO1998047520A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0106987D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeuitic agent
CA2531261A1 (en) * 2005-12-21 2007-06-21 Institut Pasteur Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
US5116612A (en) * 1987-06-23 1992-05-26 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
AU660430B2 (en) * 1990-11-08 1995-06-29 Stanford Rook Limited Mycobacterium as adjuvant for antigens
AU657345B2 (en) * 1991-05-24 1995-03-09 Northwestern University Method of using substance P to treat allergy

Also Published As

Publication number Publication date
WO1998047520A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
AU2002300464A1 (en) Apoliprotein A-I Agonist And Their Use To Treat Dyslipidemic Disorders
AU7250294A (en) Treatment of multidrug resistant diseases
ID25504A (en) PREVENTION AND TREATMENT OF AMILOIDOGENIC DISEASE
ZA966240B (en) Methods for treatment of allergic asthma.
AU2002300785A1 (en) Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
PL344977A1 (en) Therapeutic uses of quinoline derivatives
AU4078997A (en) Cholinesterase inhibitors for treatment of parkinson's disease
AU8038998A (en) Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU5908300A (en) Prevention and treatment of amyloid-associated disorders
AU1742200A (en) Prevention and treatment of amyloid-associated disorders
ZA971607B (en) Methods of treatment of allergic diseases
AU7154998A (en) Prevention and treatment of allergic disease by targeted development of protective t-helper lymphocyte immunity
AU1338801A (en) Methods of protecting neuronal function
PL322002A1 (en) Variants of human dnase i
AU5984196A (en) Treatment and prevention of prostatic disease
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU9797598A (en) Treatment of diabetic retinopathy
AU7346298A (en) Treatment of allergic conditions
GB2324962B (en) Treatment of allergic conditions
AU2002313992A1 (en) Compositions and Methods for Treatment of Mitochondrial Diseases
GB9516572D0 (en) Prevention and/or treatment of disease
AUPP076997A0 (en) Treatment of glaucoma
AU2003204277A1 (en) Treatment of hematologic disorders
AU5172796A (en) Treatment of zircon

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase